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Purpose: Photoacoustic tomography can make an image of hemoglobin 
distribution and oxygenation state inside tissue with high spatial resolution. 
The purpose of this study is to investigate its clinical usefulness for the 
diagnosis of breast cancer and the evaluation of therapeutic response in 
relation to other diagnostic modalities. 
Materials and methods: Using a prototype machine for photoacoustic 
mammography (PAM), 27 breast tumor lesions, including 21 invasive breast 
cancer (IBC), five ductal carcinoma in situ (DCIS) and one phyllodes tumor, 
were measured. Nine out of twenty one IBC patients had received primary 
systemic therapy (PST). 
Results: Eight out of twelve IBC without PST were visible. Notably, detection 
was possible in all five cases with DCIS, whereas it was not in one case with 
phyllodes tumor. Seven out of nine IBC with PST were assigned as visible in 
spite of decreased size of tumor after PST. The mean value of hemoglobin 
saturation in the visible lesions was 78.6 %, and hemoglobin concentration 
was 207 µM. The tumor images of PAM were comparable with those of MRI.  
Conclusions: It was suggested that PAM can provide images on tumor 
vascularity and oxygenation which may be useful for the diagnosis and 
characterization of breast cancer.  
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Breast cancer is one of the most common malignant diseases in 
women. Early detection and diagnosis are essential to decrease the mortality. 
In addition, as the number of cases of primary systemic therapy (PST) 
increases, efforts have been made to develop a sensitive method for 
monitoring the treatment effect [1, 2]. Conventional diagnostic modalities, 
including X-ray mammography (MMG), ultrasonography (US), and magnetic 
resonance imaging (MRI), are useful for these purposes, but each has some 
drawbacks. Mammography is associated with ionizing radiation and has 
diagnostic weakness for dense breast. The results of ultrasound greatly 
depend on the instrumental performance and examiner’s skill. MRI requires 
the use of contrast medium, which is not suitable for mass screening and 
repeated examination.  
Optical detection of breast cancer using near-infrared (NIR) light has 
drawn much attention because it can measure hemoglobin distribution and 
oxygenation state inside the tissue noninvasively [4, 5]. Angiogenesis is 
essential for breast cancer growth and also correlated with the malignant 
potential of precursor lesion [6-9]. It is known that microvessel density in the 
cancer tissue significantly decreases in the responders for PST from the early 
period [10]. Therefore, optical imaging has great potential as the basis of 
novel diagnostic modalities for breast cancer. Several studies have reported 
promising results for diffuse optical tomography (DOT) used for differential 
diagnosis and therapeutic monitoring of breast cancer [11-17]. However, at 
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present, its clinical usefulness seems to be limited due to poor spatial 
resolution. Photoacoustic tomography is another modality of optical imaging 
based on photoacoustic technology, which can make an image of hemoglobin 
distribution and oxygenation state inside tissue with higher spatial 
resolution than DOT [18- 20]. There are a few preliminary reports on such 
approaches for breast cancer [21-23]. 
In this paper, we report early results for the clinical application of 
PAM and investigate its usefulness for the diagnosis of breast cancer and the 
evaluation of therapeutic response in relation to other diagnostic modalities. 
 
Materials and methods 
 
Instruments  
A prototype machine of a dual illuminated mode photoacoustic 
tomography system (Canon Inc., Tokyo, Japan) was used [24, 25]. Figure 1 
shows a photograph of the machine and a schematic description of the 
measurement. The patient-instrument interface was a sliding bed with a 
hole of 17 cm by 18 cm, which was mounted on the frame housing 
laser-emitting and ultrasound detection units. The patient lay in a prone 
position on the bed with her breast placed in the hole. The breast was mildly 
compressed in a cranio-caudal direction between holding plates. Acoustic 
coupling gel was used between the breast and the holding plate that carried 
the scanning system. Pulsed laser beams were irradiated to the breast from 
both sides and the photoacoustic signals were detected on the caudal side by 
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an array transducer. The lasers were mounted at the bottom of the bed and 
coupled to the scanning system. A Ti:Sa laser optically pumped with a 
Q-switched Nd:YAG laser, having a tunable wavelength of 700 to 900 nm. 
The measurable area was 30 mm by 46 mm for one scan, which took 45 
seconds. In the first 16 cases, the scan was performed at three adjacent areas 
where the lesion was considered to be located in the diseased breast and one 
area in the intact breast. In the last 15 cases, the scanning system was 
automatically moved in an area of 120 mm by 46 mm. Specific parameters of 
the PAM are as follows: 
Laser  Wavelength  1064, 825, 797, 756 nm 
  Pulse width   7 ns 
  Repetition rate 10 Hz 
Detector Matrix shape  Rectangular 
  Number of elements 15 by 23 
  Element size   2 by 2 mm 
  Central frequency 1 MHz 
Photoacoustic image reconstruction was carried out using a modified 
universal backprojection algorithm. Assuming that the breast consisted of 
homogeneous tissue with known µa and µs’, the µa values of the absorbers 
were calculated from the initial pressure rise after the laser pulse using the 
equation as shown below [4]. Light fluence distribution inside the breast was 
estimated using the published data of absorption and scattering coefficients 




p0 = ΓηthµaF 
 
p0 : initial pressure after the laser pulse 
Γ : Grueneisen parameter. At body temperature, Γ = 0.20 
ηth : percentage that is converted into heat 
µa : absorption coefficient 
F : light fluence 
 
Thus, the distribution of µa in the breast was calculated from the 
initial pressure distribution at each wavelength. Oxygen saturation of 
hemoglobin (SO2) and total hemoglobin concentration (THC) of the lesions 
were calculated using µa values at 797 nm and 756 nm. Extinction 
coefficients of oxyhemoglobin and deoxyhemoglobin were used as 0.231 and 
0.259 at 797 nm, and 0.163 and 0.511 at 756 nm, respectively. 
 
Patients 
Thirty-one patients, who were histologically diagnosed with breast 
cancer or phyllodes tumor, were recruited in this study at Kyoto University 
Hospital from August 2010 to July 2011. Twenty seven breast lesions of 
twenty-six cases were subjected to analysis. The other five cases were 
excluded from analysis because the tumor was outside of the measurable 
area of PAM for the reason that the breast was too small or the tumor was 
located very near the chest wall. MMG, US, and MRI were undertaken as 
routine preoperative workup. All patients underwent breast surgeries 
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following PAM measurements within one month, and no anti-cancer 
treatment was given during the interval. The excised specimens were 
pathologically examined. For assignment of the pathological effect of PST, 
Histopathological Criteria for Assessment of Therapeutic Response of 
Japanese Breast Cancer Society were used [24], which assigned the 
pathological effect as grade 0 (no response) to grade 3 (complete response). 
Visibility assignment of PAM image was made by one of the authors who is a 
radiologist specialized in the diagnosis of breast cancer. Our procedures were 
as follows; signals which were supposed to come from vascular rich lesions or 
vessels were extracted from PAM images without considering clinical data 
including other imaging modalities. The selection criteria were the intensity 
and the morphology of the signal. Linear, winding or branched shaped 
signals were attributed to the vessels. Grouped or locally scattered signals 
were attributed to the vascular rich lesion. Usually, several signals or groups 
were extracted from one breast measurement. Each PAM signal, then, was 
correlated with that of MRI by comparing the locations. The assignment of 
the location was adjusted by the shape of subcutaneous veins which were 
demonstrated by both of PAM and MRI. When any signal was found to be 
located at the site of the tumor of known, the radiologist judged whether the 
signal was associated with the tumor considering the intensity, the shape 
and the distribution.  
The study protocol was approved by the Medical Ethical Committee 






The average age was 58.0 years (36 ~ 83 years), and the tumor size 
measured by MRI was 20.1 mm (11 ~ 70 mm). Preoperative diagnosis was 
invasive breast cancer (IBC) in twenty one breasts, including twenty 
invasive ductal carcinomas (IDC), one invasive lobular carcinoma (ILC), 
ductal carcinoma in situ (DCIS) in five cases, and phyllodes tumor in one 
case. Biological subtype of IBC was ER+/HER2- in eighteen lesions, 
ER-/HER2+ in two, and ER-/HER2- in one. PST was given in 9 out of 21 IBC 
patients. 
The tumor was assigned as visible by PAM in 20 out of 27 breasts 
(74 %), as shown in Table 1. Table 2 shows the results of IBC cases without 
PST. Eight out of twelve IBC were visible. Table 3 shows the results with 
PST. Five out of nine cases showed clinical partial response and pathological 
therapeutic effect better than grade 2 (marked response). Seven cases were 
assigned as visible in spite of decreased size of tumor after PST. Table 4 
shows the results of DCIS and phyllodes tumor. Notably, detection was 
possible in all five cases with DCIS. On the other hand, it was not possible 
with phyllodes tumor. A mean value of SO2 in the visible lesions was 78.6 % 
(53.7 ~ 100%), and THC was 207 µM (87 ~ 309 µM). 
Two particular cases of IBC with or without PST are now presented in detail. 
1) IBC without PST 
The patient was a 75-year-old woman with left breast cancer. MRI 
showed a tumor with ring enhancement with a diameter of 22 mm. 
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Pathological diagnosis was IDC (ER+/HER2+). At PAM measurement, the 
breast was compressed to a thickness of 58 mm. Figure 2 shows 
subcutaneous blood vessels by PAM. The value of SO2 ranged from 92.1% to 
98.6%. Figure 3 shows a maximum intensity projection (MIP) image of PAM 
at a depth between 7.75 and 11.5 mm, indicating clustered signals aligned in 
a ring shape and a linear-shaped signal. These signals were comparable with 
the MRI findings and considered to represent the tumor and the feeding 
vessel, respectively. Mean values of SO2 and THC in the areas with these 
signals were 87.1% and 112 µM, respectively. 
2) IBC after PST 
The patient was a 41-year-old woman with right breast cancer. The 
tumor was reduced in size from 34 mm to 22 mm in diameter after six-month 
treatment with endocrine therapy. PAM image at a depth of 28.25 mm 
showed signals comparable with those of MRI image (Figure 4). Pathological 
diagnosis was IDC (ER+/HER2-) and the therapeutic effect was assigned as 
grade 1b (moderate response). Mean values of SO2 and THC of the two 
assigned lesions were 74.5 % and 385 µM in A area, and 53.8 % and 307 µM 





Photoacoustic tomography refers to imaging that is based on the 
photoacoustic effect [4, 18-20]. When light is emitted into the tissue, some of 
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the light is absorbed by the object and partially converted into heat. The heat 
is then further converted to a pressure rise via thermoelastic expansion. The 
pressure rise is propagated as an ultrasonic wave, which is detected by 
ultrasonic transducers and is used by a computer to form an image. The 
purpose of using photoacoustic tomography is to combine the contrast of 
optical absorption with the spatial resolution of ultrasound for deep imaging 
of living tissue. Since optical absorption provides biological information 
about tissue vascularization and oxygenation state, functional imaging 
regarding tissue oxygenation can be obtained. Previous reports using animal 
models showed successful results on imaging of lympho-vascular structure 
inside tissue [20, 28, 29]. This technology has already been applied to breast 
cancer patients [21, 23], but the clinical evaluation was limited.  
We compared PAM images with MRI, since MRI is currently the most 
accurate imaging method for determining the extent of disease in the breast 
[30, 31]. As shown in Fig. 3 and 4, the tumor image of PAM was comparable 
with that of MRI demonstrating rim enhancement. These findings could be 
attributable to the distribution of higher vascular densities in the peripheral 
area of cancer. However, the tumor image of PAM was not mass-forming as 
shown by MRI. Discrepancy in the image presentation probably arises from 
the difference in distribution of contrast materials. Photoacoustic image 
represents the distribution of hemoglobin inside the vessels, whereas MRI 
image presents not only the tumor vessels but also the surrounding stroma 
where the contrast media is shed out from the vessels. In a preliminary 
study using animals and excised breast cancer specimens, the intensity of 
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PAM signal was correlated with the microvessel density in the tumor tissue 
(data not shown). 
In this study, 20 out of 27 breast cancer lesions were assigned as 
visible in PAM images. The detection rate seems acceptable, considering the 
variety of cases in this series. Previous clinical studies reported PAM images 
of breast cancer corresponding to the findings of MMG or US (21, 23) and 
detection rate similar to ours (23), but the patient population was rather 
homogeneous. This study evaluated PAM images in cases of DCIS and IDC 
with PST as well. Reasons of failure in unsuccessful cases of IBC without 
PST were mostly the small size of the breast, the breast surface deformity 
and the poor vascularity of the tumor.  
Five cases of DCIS with diameters of 63 mm and 11 mm were visible 
by PAM but phyllodes tumor with a diameter of 35 mm was not. These 
results suggest that PAM may be useful to differentiate malignant lesions 
from benign ones and also to detect breast cancer at an early stage. It was 
reported that microvascular density increased at the stage of non-invasive 
carcinoma [7, 9]. Previous studies of DOT also showed that tissue 
hemoglobin concentration was a good parameter to differentiate between 
malignant and benign lesions [15, 17]. High spatial resolution of PAM would 
be beneficial for the detection of small DCIS lesions. Further study is 
necessary to confirm these hypotheses. 
Seven out of nine cases after PST could be detected by PAM in spite 
of decreased diameter and cellularity of the tumor. As the number of cases of 
PST increases, sensitive measures monitoring therapeutic effect are 
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required [32-35]. As well as radiological imaging modalities and biological 
markers of biopsy specimens, promising results have been reported for 
optical imaging using DOT. It has been reported that hemoglobin 
concentration decreased during PST before morphological changes appeared 
and that oxygen saturation transiently increased shortly after the start of 
PST [12, 16]. Since repeated examinations along the treatment course are 
necessary, the non-invasiveness of optical imaging is beneficial. In addition, 
PAM has the possibility to monitor not only changes in hemoglobin in the 
whole tumor but also changes at a higher resolution within the tumor. 
Quantitative evaluation of tumor images by PAM must be established for the 
purpose of monitoring the effect of PST.  
This study used multiple wavelengths to measure PAM signals to 
estimate the tumor SO2 and THC, which was the first attempt of its kind in 
clinical studies. It has been reported that malignant tumor has a higher THC 
and lower SO2 than background breast tissue. According to a review paper on 
DOT [17], tumor showed THC of 65 ± 34 µM, which were 2.0~4.5-fold higher 
than the background THC. The tumor SO2 was 66 ± 24 %, which was 
0.8~0.82 fold that of the background SO2. The values of THC and SO2 of 207 
µM and 78.6 %, respectively, in breast cancer calculated in this study were 
higher than the reported data of DOT. These discrepancies are partly due to 
the difference in spatial resolution between the two imaging modalities. 
Contrast of the tumor arises from the difference of hemoglobin concentration 
between tumor and normal breast tissues in both PAM and DOT. PAM may 
select a more confined area where the tissue is more vascular-rich and 
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oxygenated than the area defined by DOT. However, there are several 
problems in quantitative evaluation of SO2 and THC by PAM; 1) Light 
distribution in the breast tissue at each wavelength should be known a priori. 
We used µa and µs’ values reported in the past literature to calculate the 
light distribution, but some deviation from the actual distribution might 
exist in each case. 2) The direction of the vessels and the shape of absorbers 
should affect the intensity of PAM signals. 3) Noise occurring at the margin 
of the breast and the boundaries of the compression plates prevents the 
quantitative measurement of initial pressure of thermo-elastic wave. Noise 
reduction is essential to quantitative evaluation of optical parameters. 
Further study is necessary to quantify these optical parameters for clinical 
use. 
Breast compression is an inevitable problem with the present method. 
We compressed the breast for two reasons: one is to make contact with the 
plate carrying the ultrasound detectors and the other is to increase the light 
fluence rate inside the breast by decreasing the breast thickness. However, 
compression at high pressure may disturb the tissue circulation [36]. Care 
was taken to apply minimal pressure so as not to change the tissue 
circulation and oxygenation. In fact, clear demonstration of subcutaneous 
vasculature and reasonable SO2 values suggested that the tissue circulation 
was fairly well maintained.  
PAM could provide images of tumor vasculature and oxygenation, 
which cannot be obtained by MMG or US. However, imaging depth and 
resolution still require improvement. At present, PAM has an advantage in 
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terms of functional features rather than morphology. The combination of 
PAM with US, as demonstrated in animal models [24, 25], would be useful to 
achieve more comprehensive imaging of breast cancer, where the biological 
and anatomical aspects can be assessed simultaneously. It was suggested 
that PAM can be useful for the diagnosis and characterization of breast 
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a) A photograph of the prototype machine: The patient-instrument interface 
was a sliding bed with a hole of 17 cm by 18 cm. The lasers were mounted 
at the bottom of the bed and coupled to the ultrasound scanning system.  
b) A schematic description of PAM measurement: Near-infrared laser pulse 
was irradiated to the breast and thermoelastic waves produced by 
absorbers in the breast were detected by ultrasound detectors.  
 
Fig. 2 
Subcutaneous blood vessels were clearly shown (depth: 1.5~2.25 mm). The 
SO2 values ranged from 92.1 % to 98.6 % 
 
Fig. 3 
IBC without PST 
Upper panel: PAM image showed clustered signals aligned in a ring (dotted 
circle) and a linear signal (arrow) (depth: 7.75~11.5 mm, breast thickness: 58 
mm). These signals were considered to represent the tumor and the feeding 
vessel, respectively. Mean values of SO2 and THC of the tumor were 87.1% 
and 112 µM, respectively. 
Lower panel: MRI showed a tumor with ring enhancement. The dotted 





IBC after PST 
Upper panel: PAM image showed clustered signals (squared areas A and B). 
(depth: 28.25 mm, breast thickness: 68 mm). Area A and B were assigned as 
peripheral part and central part of the tumor, respectively.  Mean values of 
SO2 and THC of the assigned lesions were (A) 74.5 % and 385 µM, and (B) 
53.8 % and 307 µM, respectively. 
Lower panel: MRI showed an enhanced tumor of 22 mm in size. The dotted 







Table 1. Tumor visibility by PAM images 
diagnosis Tumor visibility 
IBC without PST 8 / 12 
IBC after PST 7/ 9 
DCIS 5 / 5 
Phyllodes tumor 0 / 1 
All  20 / 27 
IBC: invasive breast cancer, PST: preoperative systemic treatment, DCIS: ductal carcinoma in situ 
  
Table 2. Results in cases of IBC without PST 










1 15 mm 17 mm ILC ER+/HER2- 2 Yes 
2 28 21 IDC ER+/HER2- 2 No 
3  19 18 IDC ER+/HER2- 2 Yes 
4 13 24 IDC ER+/HER2- 1 Yes 
5 33 24 IDC ER+/HER2- 1 No 
6 15 13 IDC + DCIS ER-/HER2+ 3 Yes 
7 22 18 IDC ER+/HER2- 2 Yes 
8 ND 19 IDC ER+/HER2- 1 No 
9 23 21 IDC ER+/HER2- 2 Yes 
10 22 22 IDC ER+/HER2- 2 Yes  
11 30 40 IDC ER+/HER2- 3 No  
12 19 15 IDC ER+/HER2- 1 Yes  
ND: not detectable, IDC: invasive ductal carcinoma, ILC: invasive lobular carcinoma,  
DCIS: ductal carcinoma in situ, ER: estrogen receptor, HER2: her2 receptor 
  
Table 3. Results in cases of IBC after PST 




Diameter  PAM 
visibility 
1 ER+/HER2- Let SD Grade 1a 10 mm Yes 
2 ER+/HER2- Let + CPA PR Grade 1b~2a 8, 13 Yes 
3 ER+/HER2- Let + CPA SD  Grade 1a 42 No 
4 ER+/HER2- Let + CPA SD Grade 2a 6 Yes  
5 ER+/HER2- LHRHa+Tam+5FU SD Grade 1b 24 Yes  
6 ER-/HER2+ FEC > D + H PR Grade 2a 11 No  
7 ER+/HER2- TC PR Grade 2a 35 Yes  
8 ER-/HER2- TP > FEC PR Grade 2a 11 Yes  
9 ER+/HER2- AP PR Grade 3* 0 Yes  
Let: letrozole, CPA: cyclophosphamide, FEC: epirubicine + 5-FU + cyclophosphamide, D: docetaxel,  
H: herceptin, TC: docetaxel + cyclophosphamide, LHRHa: lutenizing hormone releasing hormone agonist,,  
Tam: tamoxifen, TP: docetaxel + cisplatine, AP: adriamycine + cisplatine. 
SD: stable disease, PR: partial response, CR: complete response. 
*: DCIS remained 
 
Table 4. Results in cases of DCIS and phyllodes tumor  




Pathological diagnosis PAM 
visibility 
1 30 mm 30 mm DCIS, intermediate~high grade Yes 
2 11 11 DCIS, high grade Yes 
3 36 45 DCIS, intermediate grade Yes  
4 60 60 DCIS, high grade Yes  
5 70 63 DCIS, low grade Yes  
6 21 35 Phyllodes tumor, border line No 
 
